Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial (DISclRituxan)

This study is currently recruiting participants.
Verified April 2013 by Northwestern University
Sponsor:
Information provided by (Responsible Party):
Richard Burt, MD, Northwestern University
ClinicalTrials.gov Identifier:
NCT01445821
First received: September 29, 2011
Last updated: April 4, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2018
  Estimated Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)